Clinical Trial Update: Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms [Phase 3]

View source ↗

Summary

This update reports the completion of an open-label extension study of MCS-2 for lower urinary tract symptoms associated with benign prostatic hyperplasia in a …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Lower Urinary Tract Symptoms

Drugs mentioned

• MCS-2

Snippet

Sponsor: Health Ever Bio-Tech Co., Ltd. | Conditions: Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia | Phase 3 | Status: COMPLETED